Hironaga Satake

23PUBLICATIONS
99CO-AUTHORS
Cancer geneticsGeneral practicePredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 26, 2026
Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis.

|Jul 27, 2026
Facility-Level Availability of Japanese Society of Medical Oncology Specialists and Recorded First-Line Treatment-Process Duration in Pancreatic Cancer: A Nationwide Center for Cancer Genomics and Advanced Therapeutics Registry Analysis.

|Mar 25, 2026
Hypoxia and aspirin additively increase intracellular glutamine accumulation in PIK3CA-mutated colorectal cancer cells.

Nodoka Umezaki, Shogen Boku, Yoshiyuki Matsuo

|Dec 04, 2025
A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

Yoshiaki Nagatani, Naomi Kiyota, Tomoko Yamazaki

|May 23, 2025
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.

Daisuke Sakai, Shigenori Kadowaki, Ryohei Kawabata

|May 09, 2025
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study.

Kentaro Sawada, Riu Yamashita, Shunsuke A Sakai

Pageof 4

Frequent Collaborators

6 joint publications

Shogen Boku

5 joint publications

Hideaki Bando

4 joint publications

Hisateru Yasui

4 joint publications

Shigenori Kadowaki